Investors
-
Non Regulatory April 10, 2026 EnglishInitiator Pharma to present at Redeye Healthcare Day 2026
-
Regulatory February 20, 2026 EnglishINITIATOR PHARMA: Q4 2025 REPORT
-
Non Regulatory February 18, 2026 EnglishInitiator Pharma granted European patent for pudafensine in Female Sexual Dysfunction, including vulvodynia
-
Regulatory February 20, 2026 EnglishINITIATOR PHARMA: Q4 2025 REPORT
-
Regulatory November 21, 2025 EnglishCorrection: INITIATOR PHARMA: Q3 2025 REPORT
-
Regulatory November 21, 2025 EnglishINITIATOR PHARMA: Q3 2025 REPORT
Initiator Pharma Numbers
-
Expected Number of men affected by Erectile Dysfunction worldwide by 2025 322 million
-
Number of women in the US and Europe suffering from Vulvodynia 27 million
-
Men with Erectile Dysfunction who do not respond to drug therapy 40 %